New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 12, 2014
07:05 EDTVSTMVerastem announces initiation of COMMAND study in Japan
Verastem announced the expansion of its ongoing COMMAND study to include clinical trial sites in Japan. COMMAND is a registration-directed trial evaluating the Company’s lead candidate targeting cancer stem cells, VS-6063, a potent inhibitor of focal adhesion kinase, in patients with malignant pleural mesothelioma. With the inclusion of Japan, COMMAND is now accruing patients and pursuing parallel clinical development in the major markets worldwide.
News For VSTM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for VSTM

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use